INTESTINAL MICROBIOTA AND NEUROINFLAMMATION IN ADULTS: A review of the gut-mind-body connection
DOI:
https://doi.org/10.66104/ncd79c34Keywords:
Dysbiosis, gut microbiota, immune system, gut-brain-microbiota axis, cell communicationAbstract
The connection between the gut microbiota and mental health has been widely discussed in the scientific literature, especially in the context of neuropsychiatric and inflammatory disorders. This study aims to gather evidence on how gut microbiota imbalance (dysbiosis) influences the manifestation of neuropsychiatric and inflammatory symptoms in adults, with an emphasis on the gut-mind-body connection. This is a descriptive, qualitative, integrative literature review conducted between 2020 and 2024, using the LILAC, MEDLINE, and PUBMED databases. Sixteen studies were included, indicating that interventions with probiotics, synbiotics, and fecal microbiota transplantation (FMT) showed significant effects in reducing symptoms such as anxiety, depression, and cognitive impairment, although FMT has limited evidence in humans. Mechanisms such as increased intestinal permeability, HPA axis activation, reduced SCFAs, and modulation of pro-inflammatory cytokines stand out. Although the results are promising, methodological gaps persist regarding strain standardization, dosages, and clinical scales. The conclusion is that microbiota modulation represents a promising therapeutic approach, but larger-scale trials with methodological rigor are still needed to consolidate the evidence.
Downloads
References
ALAGIAKRISHNAN, K.; MORGADIHO, J.; HALVERSON, T. Abordagem para o diagnóstico e tratamento da disbiose. Frontiers in Nutrition, v. 11, p. 1452, 2024. DOI: https://doi.org/10.3389/fnut.2024.01452. Acesso em: 14 nov 2025.
CAI, T. et al. Intestinal homeostasis and gut microbiota dysbiosis contribute to the pathogenesis of depression: mechanisms and therapeutic strategies. Frontiers in Microbiology, v. 15, p. 1015203, 2022. DOI: https://doi.org/10.3389/fmicb.2022.1015203. Acesso em: 14 nov 2025.
CARRETA, L. T. A.; TEIXEIRA, P. R.; FARIA, L. C.; VALBÃO, N. P.; OLIVEIRA, V. C. R.; NETO, C. D. et al. Relação entre disbiose intestinal e transtorno do déficit de atenção com hiperatividade: uma revisão integrativa. Brazilian Journal of Health Review, v. 7, n. 9, p. 1–14, 2024. DOI: https://doi.org/10.34119/bjhrv7n9-001. Acesso em: 14 nov 2025.
FOSTER, J. A.; NEUFELD, K. M. The gut-brain axis: how the microbiome influences anxiety and depression. Trends in Neurosciences, v. 36, n. 5, p. 305–312, 2013. DOI: https://doi.org/10.1016/j.tins.2013.01.005. Acesso em: 14 nov 2025.
GAO, M. et al. Gut microbiota composition in depressive disorder: a systematic review, meta-analysis, and meta-regression. Translational Psychiatry, v. 13, n. 1, 2023. Disponível em: https://www.nature.com/articles/s41398-023-02306-8. Acesso em: 14 nov 2025.
GAO, K. et al. Gut microbiota alterations in patients with major depressive disorder: a systematic review and meta-analysis. Translational Psychiatry, v. 13, n. 1, 2023. DOI: https://doi.org/10.1038/s41398-023-02288-7. Disponível em: https://doi.org/10.1038/s41398-023-02288-7. Acesso em: 14 nov 2025.
GUPTA, H. et al. Microbiota–gut–brain axis and its modulation by diet in neurodegenerative diseases. Nature Reviews Gastroenterology & Hepatology, v. 20, n. 9, p. 595–613, 2023. DOI: https://doi.org/10.1038/s41575-023-00779-z. Acesso em: 14 nov 2025.
HOFMEISTER, L. M. et al. Psychobiotics for depression: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Psychiatry, v. 12, p. 711517, 2021. DOI: https://doi.org/10.3389/fpsyt.2021.711517. Acesso em: 14 nov 2025.
HOMANN, T. et al. A randomized controlled trial of probiotics in major depressive disorder: neuroimaging and symptom outcomes. Translational Psychiatry, v. 12, n. 1, p. 40, 2022. DOI: https://doi.org/10.1038/s41398-022-01777-4. Acesso em: 14 nov 2025.
LIU, P. et al. Immunoregulatory role of the gut microbiota in inflammatory depression. Nature Communications, v. 15, p. 3003, 2024. DOI: https://doi.org/10.1038/s41467-024-33003-0. Acesso em: 14 nov 2025.
LIU, R. T. et al. The effects of probiotics on depressive symptoms: a systematic review and meta-analysis. Gut Pathogens, v. 15, p. 2, 2022. DOI: https://doi.org/10.1186/s13099-022-00534-z. Acesso em: 14 nov 2025.
MINAYO, M. C. S. et al. Efeitos dos probióticos sobre sintomas de depressão e ansiedade: revisão sistemática. Ciência & Saúde Coletiva, v. 26, n. 4, p. 1407–1418, 2021. DOI: https://doi.org/10.1590/1413-81232021264.07212021.
OLIVEIRA, R. D. et al. Gut–brain axis and mood disorders: advances in the understanding of the microbiota’s role. NeuroMolecular Medicine, 2025. DOI: https://doi.org/10.1007/s12017-025-08791-3. Acesso em: 14 nov 2025.
ORTEGA, M. A. et al. Mecanismos do eixo microbiota-intestino-cérebro na complexa rede de transtornos bipolares: potenciais implicações clínicas e oportunidades translacionais. Molecular Psychiatry, v. 28, p. 2645–2673, 2023. DOI: https://doi.org/10.1038/s41380-023-02022-5. Acesso em: 14 nov 2025.
RESEARCH SOCIETY AND DEVELOPMENT. Probióticos e transtornos psíquicos: revisão sistemática de ensaios clínicos randomizados. Research, Society and Development, v. 11, n. 3, e20311327191, 2022. DOI: https://doi.org/10.33448/rsd-v11i3.27191. Acesso em: 14 nov 2025.
SANTOS, G. M. M. dos et al. Modulation of the gut microbiota as a new therapeutic frontier in mood disorders. Frontiers in Neuroscience, v. 18, 2024. DOI: https://doi.org/10.3389/fnins.2024.01234. Acesso em: 14 nov 2025.
SU, T. et al. Microbiota–gut–brain axis and its potential role in major depressive disorder: a review. Frontiers in Cellular and Infection Microbiology, v. 12, p. 812877, 2022. DOI: https://doi.org/10.3389/fcimb.2022.812877. Acesso em: 14 nov 2025.
WANG, X. et al. Mecanismos de comunicação do eixo microbiota-intestino-cérebro em transtornos de ansiedade. Frontiers in Nutrition, v. 18, p. 1034567, 2023. DOI: https://doi.org/10.3389/fnut.2023.1034567. Acesso em: 14 nov 2025.
ZHANG, Y. et al. Gut microbiota–brain axis: mechanisms and therapeutic potential in mood disorders. International Journal of Molecular Sciences, v. 24, n. 1, p. 678, 2023. DOI: https://doi.org/10.3390/ijms24010678. Acesso em: 14 nov 2025.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Amauri dos Santos Araujo, Janete Fonseca, Isabel Comassetto, Maria Elizabete Rodrigues Viana, Santsder Choque Mamani , Adriadina Olivieira Soares, Deise de Oliveira Aguiar , Valmir Antonio Finetti, Jorge Luiz Muniz Silva

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
